🔎 Trials Near Me

Home › B-Cell Lymphoma › Texas › Dallas

B-Cell Lymphoma clinical trials in Dallas, TX

7 studies for B-Cell Lymphoma are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

RecruitingPhase 1/2
  • Baylor Scott & White Research Institute, Texas Oncology, Dallas
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06343311

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

RecruitingPhase 1/2
  • University of Texas Southwestern Medical Center, Dallas
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07439653

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
  • University of Texas Southwestern, Dallas
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
  • Baylor University Medical Center, Dallas
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

DALY II USA/ MB-CART2019.1 for DLBCL

RecruitingPhase 2
  • UT Southwestern Medical Center, Dallas
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT04792489

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RecruitingPhase 1/2
  • University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • University of Texas, Southwestern, Dallas
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

B-Cell Lymphoma trials in other cities

Other studies in Dallas

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.